Hart Daniel Ryan has been a registered insider since 2003.
As Chief Financial Officer at Peregrine Pharmaceuticals Inc., Hart Daniel Ryan last made a transaction on 12/26/2024.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
Nq |
Hit Rate
|
Mean Return
|
Median Return
|
Range of Returns
|
Time From Purchases
|
Nq |
Hit Rate
|
Mean Return
|
Median Return
|
Range of Returns
|
1 |
100% |
343% |
-- |
-- |
1 Year |
1 |
0% |
-- |
-- |
-- |
1 |
100% |
156% |
-- |
-- |
9 Month |
1 |
0% |
-- |
-- |
-- |
1 |
100% |
89% |
-- |
-- |
6 Month |
1 |
0% |
-- |
-- |
-- |
1 |
100% |
46% |
-- |
-- |
3 Month |
1 |
0% |
-- |
-- |
-- |
1 |
100% |
8% |
-- |
-- |
1 Month |
1 |
0% |
-- |
-- |
-- |
1 |
0% |
-4% |
-- |
-- |
1 Week |
1 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
Nq |
Hit Rate
|
Mean Return
|
Median Return
|
Range of Returns
|
Time From Sales
|
Nq |
Hit Rate
|
Mean Return
|
Median Return
|
Range of Returns
|
18 |
78% |
-14% |
-35% |
322 |
1 Year |
18 |
0% |
-- |
-- |
-- |
19 |
74% |
-13% |
-22% |
241 |
9 Month |
19 |
0% |
-- |
-- |
-- |
19 |
79% |
-17% |
-20% |
137 |
6 Month |
19 |
0% |
-- |
-- |
-- |
19 |
74% |
-10% |
-9% |
63 |
3 Month |
19 |
0% |
-- |
-- |
-- |
20 |
65% |
-3% |
-4% |
89 |
1 Month |
20 |
0% |
-- |
-- |
-- |
20 |
70% |
-2% |
-1% |
34 |
1 Week |
20 |
0% |
-- |
-- |
-- |
Scorecards Updated 4/3/2025 05:39 AM EST |
Latest Transaction Date: |
12/26/2024 |
Average days between Transaction and Entered Dates: |
2 |